Cargando…

Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it

The IgA receptor, Fcar (CD89) consists of 5 sequence segments: 2 segments (S1, S2) forming the potential signal peptide, 2 extracellular EC domains that include the IgA binding site, and the transmembrane and cytoplasmic tail (TM/C) region. Numerous Fcar splice variants have been reported with vario...

Descripción completa

Detalles Bibliográficos
Autores principales: Lua, Wai-Heng, Ling, Wei-Li, Su, Chinh Tran-To, Yeo, Joshua Yi, Verma, Chandra Shekhar, Eisenhaber, Birgit, Eisenhaber, Frank, Gan, Samuel Ken-En
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351921/
https://www.ncbi.nlm.nih.gov/pubmed/28103138
http://dx.doi.org/10.1080/15384101.2017.1281480
_version_ 1782514844508880896
author Lua, Wai-Heng
Ling, Wei-Li
Su, Chinh Tran-To
Yeo, Joshua Yi
Verma, Chandra Shekhar
Eisenhaber, Birgit
Eisenhaber, Frank
Gan, Samuel Ken-En
author_facet Lua, Wai-Heng
Ling, Wei-Li
Su, Chinh Tran-To
Yeo, Joshua Yi
Verma, Chandra Shekhar
Eisenhaber, Birgit
Eisenhaber, Frank
Gan, Samuel Ken-En
author_sort Lua, Wai-Heng
collection PubMed
description The IgA receptor, Fcar (CD89) consists of 5 sequence segments: 2 segments (S1, S2) forming the potential signal peptide, 2 extracellular EC domains that include the IgA binding site, and the transmembrane and cytoplasmic tail (TM/C) region. Numerous Fcar splice variants have been reported with various combinations of the sequence segments mentioned above. Here, we report a novel splice variant termed variant APD isolated from a healthy volunteer that lacks only the IgA-binding EC1 domain. Despite possessing the complete signal peptide S1+S2, the variant APD is only found in the intracellular space whereas the wild-type variant 1 is efficiently secreted and variant 4 leaks to the extracellular space. Further mutational experiments involving signal peptide replacements, cleavage site modifications, and studies on alternative isoforms demonstrate that despite the completeness of the signal peptide motif, the presence of the EC1 domain is essential for efficient extracellular export.
format Online
Article
Text
id pubmed-5351921
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-53519212017-03-24 Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it Lua, Wai-Heng Ling, Wei-Li Su, Chinh Tran-To Yeo, Joshua Yi Verma, Chandra Shekhar Eisenhaber, Birgit Eisenhaber, Frank Gan, Samuel Ken-En Cell Cycle Reports The IgA receptor, Fcar (CD89) consists of 5 sequence segments: 2 segments (S1, S2) forming the potential signal peptide, 2 extracellular EC domains that include the IgA binding site, and the transmembrane and cytoplasmic tail (TM/C) region. Numerous Fcar splice variants have been reported with various combinations of the sequence segments mentioned above. Here, we report a novel splice variant termed variant APD isolated from a healthy volunteer that lacks only the IgA-binding EC1 domain. Despite possessing the complete signal peptide S1+S2, the variant APD is only found in the intracellular space whereas the wild-type variant 1 is efficiently secreted and variant 4 leaks to the extracellular space. Further mutational experiments involving signal peptide replacements, cleavage site modifications, and studies on alternative isoforms demonstrate that despite the completeness of the signal peptide motif, the presence of the EC1 domain is essential for efficient extracellular export. Taylor & Francis 2017-01-19 /pmc/articles/PMC5351921/ /pubmed/28103138 http://dx.doi.org/10.1080/15384101.2017.1281480 Text en © 2017 The Author(s). Published with license by Taylor & Francis http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Reports
Lua, Wai-Heng
Ling, Wei-Li
Su, Chinh Tran-To
Yeo, Joshua Yi
Verma, Chandra Shekhar
Eisenhaber, Birgit
Eisenhaber, Frank
Gan, Samuel Ken-En
Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it
title Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it
title_full Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it
title_fullStr Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it
title_full_unstemmed Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it
title_short Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it
title_sort discovery of a novel splice variant of fcar (cd89) unravels sequence segments necessary for efficient secretion: a story of bad signal peptides and good ones that nevertheless do not make it
topic Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351921/
https://www.ncbi.nlm.nih.gov/pubmed/28103138
http://dx.doi.org/10.1080/15384101.2017.1281480
work_keys_str_mv AT luawaiheng discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit
AT lingweili discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit
AT suchinhtranto discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit
AT yeojoshuayi discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit
AT vermachandrashekhar discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit
AT eisenhaberbirgit discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit
AT eisenhaberfrank discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit
AT gansamuelkenen discoveryofanovelsplicevariantoffcarcd89unravelssequencesegmentsnecessaryforefficientsecretionastoryofbadsignalpeptidesandgoodonesthatneverthelessdonotmakeit